These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 12939640

  • 1. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.
    Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA.
    Gene Ther; 2003 Sep; 10(20):1735-43. PubMed ID: 12939640
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
    Cheng SL, Lou J, Wright NM, Lai CF, Avioli LV, Riew KD.
    Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352
    [Abstract] [Full Text] [Related]

  • 3. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
    Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C.
    J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
    [Abstract] [Full Text] [Related]

  • 4. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
    Zachos TA, Shields KM, Bertone AL.
    J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
    [Abstract] [Full Text] [Related]

  • 5. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman JR, Wang JC.
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
    Park J, Ries J, Gelse K, Kloss F, von der Mark K, Wiltfang J, Neukam FW, Schneider H.
    Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
    [Abstract] [Full Text] [Related]

  • 8. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
    Virk MS, Conduah A, Park SH, Liu N, Sugiyama O, Cuomo A, Kang C, Lieberman JR.
    Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone formation following transplantation of genetically modified primary bone marrow stromal cells.
    Sugiyama O, Orimo H, Suzuki S, Yamashita K, Ito H, Shimada T.
    J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy.
    Li JZ, Li H, Hankins GR, Dunford B, Helm GA.
    Gene Ther; 2005 Aug; 12(16):1235-41. PubMed ID: 16034461
    [Abstract] [Full Text] [Related]

  • 13. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
    Miyazaki M, Sugiyama O, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Virk MS, Lieberman JR, Wang JC.
    Spine (Phila Pa 1976); 2008 Jun 01; 33(13):1410-7. PubMed ID: 18475244
    [Abstract] [Full Text] [Related]

  • 14. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.
    Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, Vrahas MS, Bouxsein ML, Evans CH.
    Gene Ther; 2007 Jul 01; 14(13):1039-44. PubMed ID: 17460719
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering.
    Chuang CK, Sung LY, Hwang SM, Lo WH, Chen HC, Hu YC.
    Gene Ther; 2007 Oct 01; 14(19):1417-24. PubMed ID: 17637796
    [Abstract] [Full Text] [Related]

  • 18. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages.
    Ishikawa H, Kitoh H, Sugiura F, Ishiguro N.
    Acta Orthop; 2007 Apr 01; 78(2):285-92. PubMed ID: 17464620
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector.
    Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI.
    J Bone Joint Surg Am; 2001 Apr 01; 83-A Suppl 1(Pt 2):S99-104. PubMed ID: 11314802
    [Abstract] [Full Text] [Related]

  • 20. The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells.
    Gilbertson L, Ahn SH, Teng PN, Studer RK, Niyibizi C, Kang JD.
    Spine J; 2008 Apr 01; 8(3):449-56. PubMed ID: 18455111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.